1 Curriculum Vitae Dan Atar, MD, PD, Professor, FESC Place and Date of Birth Freiburg i.Br., Germany; 12.1.1959 Present Position and Address • Secretary/Treasurer of the ESC • Professor of Cardiology, Dept. of Cardiology B Head of Research, Div. of Medicine Oslo University Hospital N – 0450 Oslo, Norway Training and Education • Medical School at University of Basel, Switzerland, graduated MD (Dr.med.) in 1985 • Internship at Copenhagen University Hospital (Rigshospitalet), Denmark • Residency in Internal Medicine at University Hospital of Basel, Switzerland st • Cardiology Fellowship (1 part) at Copenhagen University Hospital (Rigshospitalet), Denmark • Postdoctoral Research Fellowship at The Johns Hopkins University, Baltimore, Maryland, USA (1990-1994) nd • Cardiology Fellowship (2 part) at Basel University Hospital, Switzerland • Interventional Fellowship and Junior Faculty member, Zürich University Hospital, Cardiology, Switzerland Post Graduate Degrees • PD (Privatdozent; Associate Professor), University of Basel, Switzerland (1995) • PD (Privatdozent, Associate Professor), University of Zürich, Switzerland (1997) • Visiting Associate Professor of Medicine, The Johns Hopkins University, Baltimore, MD, USA (1998) • Full Professorship in Cardiology, University of Oslo, Norway (since 2002) European Society of Cardiology Activities • Past Chairman, WG “Cardiovascular Pharmacology and Drug Therapy” (now Assoc. Nucleus Member) • Member, WG “Thrombosis”, “Acute Cardiac Care Association”, “HFA” and "EHRA" • Member of the CPC (Congress Program Committee), 2006-2018 • Member of several Guidelines Task Forces and writing committees: - The 2007 ESC “Joint Prevention guidelines” - The 2008 “ESC guidelines on Acute and Chronic Heart Failure” - ESC position paper on “Bleeding complications in ACS” (2009) - The 2010 “ESC guidelines on Atrial Fibrillation” - The 2012 ESC “Atrial Fibrillation guidelines update” - The 2012 ESC “STEMI-guidelines” - The ESC/AHA/ACC/WHF 2012 “Universal Definition of Myocardial Infarction” - The 2016 ESC "Atrial Fibrillation guidelines" - The ESC/AHA/ACC/WHF 2018 “Universal Definition of Myocardial Infarction” 2 • Member of the Basic Science Council of the ESC • Executive Board member and treasurer of the Norwegian Society of Cardiology 2005-2013 • President of the National congress in 2007 and the Nordic-Baltic international Cardiology Congress in 2013. • Elected Councillor of the 2012-2014 ESC Board (Task: International Relations) • Member of the Publications Task Force 2012-2014 • Elected Vice-President of the 2014-2016 ESC Board (Task: National Affairs, CoT and Editors Network) • Chair of the "Membership Task Force" 2014-2016 (leading to a new Membership scheme as of 2016) • Member of the ESC Media Committee 2016-2018 • Elected Secretary/Treasurer of the ESC (2018-current) Other International Scientific Committee Participation • A large number of International Trial Steering Committees within antithrombotics, STEMI, AFib., and HF • Assignment to several DSMBs and Clinical Endpoint / Clinical Adjudication Committees • Regular assessor of professorships and for a number of international competitive research grants (e.g., German Research Foundation DFG, Finnish Academy of Sciences, Danish National Foundation, Swiss Science Academy, etc) Editorship / Editorial Boards • Editor-in-Chief: “Cardiology” (Karger) • Immediate-past Associate Editor: "European Heart Journal - Cardiovascular Pharmacotherapy" • Editorial Board: “European Heart Journal” • Editorial Board: “Cardiovascular Diabetology”, "Geriatric Cardiology" and 5 other journals Fellowships / Honours • F.E.S.C., F.A.C.C., Inaugural F.A.H.A. • Winner of the 1994 ISHR Research Award Competition • Winner of the 1996 Cardiology Award of the Swiss Heart Foundation • Recipient of the “Cloëtta Foundation Postdoctoral Award” 1996, Basel, Switzerland • Recipient of the “Andreas Grüntzig Award in Interventional Cardiology”, 1997, Zurich, Switzerland • Winner of the 2014 Scientific Award ("Storstein's Award") of the Norwegian Society of Cardiology • Doctor honoris causa - 2016 Major Publications • Overall >420 peer-reviewed articles. Several book-chapters . • H-index 67 • Placed since 2016/2017 on the Thompson-Reuters List "The Most Cited Researchers in the World" • Publications in Circ.Res, JBC and JMCC on myocardial stunning; publications on troponin in Circulation. Editorials in the BMJ on AMI diagnosis and -treatment • Presentation of The FIRE-trial in JACC, Presentation of the MITOCARE-trial in the EHJ (both Hotline at ESC) • A number of NEJM co-authorships of clinical trials: ARISTOTLE, ASCEND-HF, PALLAS, APPRAISE-II Major Research Interest • Myocardial function in STEMI, particularly regarding the aspect of “prevention of reperfusion injury” • Cardiovascular pharmacotherapy, particularly trial science and atrial fibrillation • Biomarkers • 2010-2014: Chairing a Clinical Trial Consortium under the EU-FP7 “MITOCARE”: a STEMI trial • Chair, academic multicenter study: The "BETAMI"-trial (Betablockers post AMI, years 2018-2022). 3 Motivation Letter Dear Colleagues, I am herewith applying to become President-Elect of our esteemed society. The "cradle" of my ESC activities has been centered around the Scientific Constituent Bodies. I enjoyed profoundly the work in the nucleus of the Working Group on Pharmacotherapy which I had the pleasure to chair in 2006-2008. I have gained broad insight into the various roles of Associations, Councils, and Working Groups through my membership and active participation in several of these. When I served as Councilor on the 2012-2014 ESC Board, my allocated task, on the other hand, was dedicated to the Affiliated Cardiac Societies outside of Europe. Next, my duties as Vice-President on the subsequent 2014-2016 ESC Board were focused on the National Cardiac Societies, the Cardiologists of Tomorrow and the Editors' Network. By reinforcing visits to the National Societies, I learned a lot about the diversity of our Society, and what is important to the different countries, with different cultures and healthcare systems. Finally, in my current role as Treasurer, I have gained profound insights about the economic status of our society. Engaging in purely scientific tasks has, however, remained the core of my fulfilment within our Society, and I feel I have been highly rewarded by the efforts put into 9 Guideline Writing Committees as well as the privilege of presenting at our ESC congresses at several Hotline sessions. Visions for the European Society of Cardiology Building on the current, outstanding strategic plan, the major pillars of 'Science', 'Education' and 'Congress' will continue to be high-priority focus areas of the ESC, with a particular need of relentless adaption to new environments in media, technology and communication. One focus will also be on membership, i.e., a more individualized approach to belonging. Further, Advocacy will be further developed thanks to the incessant opportunities from our Brussels operational platform. And finally, the aphorism of "our diversity is our strength" will be kept alive by both embracing and keeping together all our scientific bodies (i.e., Associations, Working Groups, and Councils), and by serving our various membership countries, representing geographical and cultural diversity. The future is bright for the ESC but hard work will be required to accomplish our goals. May I finally humbly point to my extensive knowledge of the ESC “from within”, having served on the previously listed positions during the last 15 years. This knowledge will safeguard continuity to the society, and at the same time allow for evolution and innovation. Taken together, my election would bring to the ESC an energetic and solid leadership role of experience, dedication and integrity. Colleagues and friends: I herewith declare that I am willing to dedicate enough time for the task as President-Elect, a fact that is fully supported by both my family and my employer. My sincere thank you for considering your support of my candidacy. With very best regards, Dan Atar .